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The question to solve in the present work is: what is the predominant action induced by
the activation of cholinergic-nicotinic receptors (nAChrs) in the striatal network given that
nAChrs are expressed by several elements of the circuit: cortical terminals, dopamine
terminals, and various striatal GABAergic interneurons. To answer this question some
type of multicellular recording has to be used without losing single cell resolution.
Here, we used calcium imaging and nicotine. It is known that in the presence of
low micromolar N-Methyl-D-aspartate (NMDA), the striatal microcircuit exhibits neuronal
activity consisting in the spontaneous synchronization of different neuron pools that
interchange their activity following determined sequences. The striatal circuit also exhibits
profuse spontaneous activity in pathological states (without NMDA) such as dopamine
depletion. However, in this case, most pathological activity is mostly generated by the
same neuron pool. Here, we show that both types of activity are inhibited during the
application of nicotine. Nicotine actions were blocked by mecamylamine, a non-specific
antagonist of nAChrs. Interestingly, inhibitory actions of nicotine were also blocked by
the GABAA-receptor antagonist bicuculline, in which case, the actions of nicotine on the
circuit became excitatory and facilitated neuronal synchronization. We conclude that the
predominant action of nicotine in the striatal microcircuit is indirect, via the activation of
networks of inhibitory interneurons. This action inhibits striatal pathological activity in early
Parkinsonian animals almost as potently as L-DOPA.
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INTRODUCTION
The striatal microcircuit is composed of projection neurons and
different classes of interneurons (e.g., Kawaguchi, 1993; Tepper
and Bolam, 2004; Tepper et al., 2010). This circuit receives inputs
from the cortex, the substantia nigra compacta (SNc) and the tha-
lamus, among others, being a main entrance to the basal ganglia,
a system of nuclei which encodes movement, associative learn-
ing, and procedural memory (Cools, 1980; DeLong, 1981; Aosaki
et al., 1994; Kreitzer and Malenka, 2008; Do et al., 2012).
Although striatal projection neurons (SPNs) have low rates
of basal firing in control conditions (e.g., Mink, 2003), uncor-
related excitatory drives such as N-Methyl-D-aspartate (2–5μM
NMDA) induces correlated neuronal activity in the control stri-
atal microcircuit in vitro (Carrillo-Reid et al., 2008); similar
to that produced during movement in vivo (Vautrelle et al.,
2009). This activity consists in moments of recurrent and spon-
taneous synchronization in the firing of different neuron pools.
This synchronous activity is alternated among the different neu-
ron pools, generating the appearance of determined sequences,
some of them being reverberant sequences or cycles (Carrillo-
Reid et al., 2008, 2009a). These dynamics have been shown to
be modulated by transmitters acting through G-protein cou-
pled receptors and signaling pathways such as those activated by
dopamine (DA) and acetyl-choline (ACh) (Carrillo-Reid et al.,
2009a, 2011).
On the other hand, when deprived of DA supply, as in ani-
mal models of Parkinson’s disease (PD), the striatal circuitry
also generates a profuse spontaneous and synchronized activity
without the addition of NMDA or any other excitatory drive.
However, this pathological activity induced by DA-depletion dif-
fers from that found in control tissue: it is characterized by the
loss of sequential activity and alternating dynamics. Almost all
activity becomes generated by the same neuron pool with recur-
rent synchronization, resembling the repetitive oscillations found
in Parkinsonian subjects (Jáidar et al., 2010). Here, we show
that both control (with NMDA) and Parkinsonian activities are
globally suppressed by nicotine administration.
The ACh present in the striatal microcircuit is released by local
cholinergic interneurons and is the highest in any brain region
together with the levels of choline acetyl-transferase, and choline-
esterase (Mesulam et al., 1992; Contant et al., 1996; Goldberg
et al., 2012). Cholinergic interneurons are autonomous pacemak-
ers and ACh release is continuous and dynamic, thus, producing
a varying tonic level of ACh in the whole striatum according to
demand (Bennett andWilson, 1999; Goldberg andWilson, 2005).
The majority of the neurons (>90%) in the striatal circuit are
SPNs which respond to ACh via muscarinic G-protein coupled
receptors (Galarraga et al., 1999; Alcantara et al., 2001; Yan et al.,
2001; Zhang et al., 2002). Known actions of these muscarinic
receptors are facilitatory due in part to suppression of K+-
outward currents, directly or indirectly (Howe and Surmeier,
1995; Gabel and Nisenbaum, 1999; Galarraga et al., 1999; Lin
et al., 2004; Olson et al., 2005; Pérez-Burgos et al., 2008; Pérez-
Rosello et al., 2005; Shen et al., 2005).
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However, much less is known about the nicotinic receptors
present in this circuit (Goldberg et al., 2012). It is known that
nAChRs are present in striatal dopaminergic terminals and pro-
mote DA release (e.g., Wonnacott et al., 2000; Grady et al., 2007;
Keath et al., 2007; Livingstone and Wonnacott, 2009; Xiao et al.,
2009; Cachope et al., 2012; Threlfell et al., 2012). It is also known
that they are present in the terminals of cortical afferents and
promote glutamate release (e.g., Marchi et al., 2002; Zhang and
Warren, 2002; Campos et al., 2010). Finally, they are present in
striatal GABAergic interneurons promoting GABA release that
inhibits projection neurons (Koós and Tepper, 2002; Wilson,
2004; Kreitzer and Malenka, 2008; Livingstone and Wonnacott,
2009; Xiao et al., 2009; English et al., 2011; Ibáñez-Sandoval et al.,
2011; Luo et al., 2013). Each of these actions has been studied
directly and separately in cell-focused studies. However, it is not
known which of them predominate in the microcircuit as a whole
during nAChrs agonist administration.
Note that, if actions on glutamate afferents were predominant,
we should see an enhancement of activity similar to that produced
by NMDA alone, and a summation of effects would be evident.
On the other hand, if the release of DA were the main action,
mixed effects would appear: some interneurons are activated by
DA, although their GABA release may be inhibited, being hard to
foretell what is the net result (Bracci et al., 2002; Centonze et al.,
2003). Activation of interneurons may enhance inhibition due
to cholinergic activation. But at the network level, SPNs may be
inhibited or excited by DA (e.g., Kiyatkin and Rebec, 1996), and
both classes of DA-receptors, D1 and D2, increase synchronous
firing (Carrillo-Reid et al., 2011). In addition, in the DA-depleted
circuit, activity increases pathologically (Jáidar et al., 2010) while
collateral inhibition is decreased (Taverna et al., 2008). In sum-
mary, a host of mixed and parallel actions makes hard to foretell
what would be the global action of nicotinic receptors activation
on the striatal microcircuit.
The importance of answering this question resides in the sus-
pected neuro-protective action of nicotine in the prevention and
development of PD (e.g., Costa et al., 2001; Quik et al., 2007;
Kawamata et al., 2012). Although this postulate is still controver-
sial (García-Montes et al., 2012), the hypothesis has its origin in
epidemiological studies that claim less incidence of PD in smok-
ers (Gorell et al., 1999; Herman et al., 2001; Driver et al., 2009),
and in clinical studies that claim improvements of motor and
cognitive symptoms in PD patients subjected to nicotine analogs
(Fagerström et al., 1994; Villafane et al., 2007). From these argu-
ments comes the importance of knowing with certainty what
would be the end result of administering a tonic level of a nAChrs
agonist in the striatal circuit, which in the present case is seen
as a neuronal population of diverse elements capable to generate
assembly dynamics (Carrillo-Reid et al., 2008) and involved in the
generation of PD signs and symptoms.
MATERIALS AND METHODS
SLICE PREPARATION
Corticostriatal slices (300μm) were obtained from PD20-40 male
mice as previously described (Vergara et al., 2003). Animal exper-
imentation followed the National Institutes of Health Guide for
Care and Use of Laboratory Animals and the National University
of Mexico guidelines. Slices were obtained with ice-cold saline
(4◦C) containing in mM: 123 NaCl, 3.5 KCl, 1 MgCl2, 1.5 CaCl2,
26 NaHCO3, and 11 glucose (saturated with 95% O2 and 5%
CO2). Slices remained in saline at room temperature (21–25◦C)
for at least 1 h before the experiments.
OPTICAL RECORDINGS OF NEURONAL POPULATIONS WITH SINGLE
CELL RESOLUTION
Slices were incubated in the dark with 10μM of the calcium
indicator fluo-8 AM for about 20min (Tef Labs, Austin, TX)
in saline containing 0.1% dimethylsulphoxide (DMSO), equi-
librated with 95% O2 and 5% CO2. We used an upright
microscope equipped with a 10X, 0.95 NA water-immersion
objective (E600FN Eclipse, Nikon, Melville, NY). To observe
the changes in fluorescence we delivered pulses at 488 nm
(50–100ms exposure) to the preparation with a Lambda LS
illuminator (Sutter instruments, Novato CA) connected to the
microscope via fiber optics. The image field was 800 × 600μm
in size. Short movies (∼180 s = epoch) were acquired at
time intervals of 5–20min during ≥60min with a cooled dig-
ital camera (SenSys 1401E, Roper Scientific, Tucson, AZ) at
100–250ms/frame.
Neurons active during the experiment (30 to 300 depend-
ing on number of epochs and age of animals; Carrillo-Reid
et al., 2008) were identified due to their spontaneous cal-
cium transients. They were recorded in control saline or dur-
ing the application of NMDA and/or nicotine with or without
ionotropic channel blockers such as: 6-cyano-2, 3-dihydroxy-7-
nitro-quinoxaline disodium salt (10μMCNQX), D-(-)-2-amino-
5-phosphonovaleric acid (50μM APV), bicuculline (10μM) or
gabazine (10μM) (Sigma-Aldrich-RBI, St. Louis, MO). Stock
solutions were prepared before experiments and added to the
recording chamber in the final concentration indicated.
IMAGE PROCESSING
Neurons active in the field of view were selected automatically
by a custom made program written in the LabView™ program-
ming environment. The program processes the image sequence
obtaining the fluorescence signals originated from action poten-
tials discharge (Carrillo-Reid et al., 2008, 2009a). Briefly, a two
dimensional coordinate was assigned for each cell. Each neuron
was numbered and its precise location in the field of view was
known. Calcium transients represent changes in fluorescence: (Fi-
Fo)/Fo, where Fi denotes the fluorescence intensity at any frame
and Fo denotes the basal fluorescence of each neuron. As it has
been reported (Carrillo-Reid et al., 2008, 2009b; Jáidar et al.,
2010) the first time derivative of the calcium transient reflects
the time of electrical discharge of striatal neurons (>2.5 times the
standard deviation of the noise value), in this way, the electrical
activity of each neuron in the field of view could be followed along
the experiment.
We constructed binary matrixes with the activity of dozens of
neurons recorded simultaneously (raster plots). In each matrix,
each row denotes an active neuron (numbered), while each col-
umn represents a time frame when an image was taken. Time
axis represents the total number of frames making each movie
converted into a minutes scale. For analysis, we considered
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calcium transients elicited by neurons only. Signals from neu-
rons are much faster than signals from glial cells (Ikegaya et al.,
2004; Sasaki et al., 2007; Carrillo-Reid et al., 2008). To visu-
alize electrical activity from several active neurons, the binary
matrix was plotted as a raster plot where neuronal firing is
represented by dots. The activity histogram, shown below the
raster plot, illustrates population activity of all neurons recorded
during an experiment; it is obtained by the addition of all
active neurons in each frame. Each spontaneous peak of syn-
chronous activity denotes a pool of several neurons firing together
(or having closely correlated activity). Note that each peak of
synchronization is a neuronal column vector. Different colors
denote that neuronal vectors are composed of different neuron
pools.
STATISTICAL METHODS
Statistically significant peaks of co-active neurons were vector-
ized identified and counted (Carrillo-Reid et al., 2008), therefore,
the level of correlated firing in the network can be quantitatively
assessed and statistically compared. To assess the probability that a
given peak of synchronization had appeared by chance, the points
of the same matrix (raster plot) were used for MonteCarlo sim-
ulations with 10,000 replications. Thus, a level of significance is
marked (dashed line) for all activity histograms. All the peaks
of synchronization denoted by colors surpassed the significance
level (P < 0.05). In control conditions without NMDA there are
no significant peaks of synchronization. However, they appear
in control tissue after adding NMDA. In addition they appear
without NMDA when the tissue is depleted of dopamine (DA-
depleted). If a treatment suppress NMDA-induced activity or
DA-depletion induced activity, significant peaks of synchroniza-
tion may go away in the activity histogram and the matrix only
contains black dots denoting a decrease of network activity.
The sequence of peaks of synchronization in the activity his-
togram denotes the activity of the microcircuit along time, that
is, a sequence of neuron pools synchronizing their firing and
alternating their activity with other neuron pools. This type of
circuit behavior has been called assembly dynamics (e.g., Carrillo-
Reid et al., 2008). To know whether synchronization increased or
decreased after a given treatment, the number of neuronal vectors
was counted in each of several image sequences (epochs) at dif-
ferent times in the same experiment. Mean of averages from dif-
ferent slices were lumped together and a free-distribution statistic
was employed (Mann-Whitney’s U) for comparison. A Wilcoxon
T-test was used to compare the same slice under different con-
ditions. Note that each 3min epoch commonly has dozens of
individual cells. For comparison of epochs from different slices
(Figure 3) the Kruskal-Wallis one way analysis of variance was
used with post hoc Dunn tests.
These peaks of synchronization denote neuronal vectors that
represent microcircuit activity in a multidimensional space,
where the number of dimensions is given by the total number
of active cells in each vector. Vectorization of network activity
along the experiment allows the searching of recurrent patterns
of activity, i.e., vectors being active repeatedly or different vec-
tors alternating their activity (Schreiber et al., 2003; Ikegaya
et al., 2004; Brown and Williams, 2005; Carrillo-Reid et al.,
2008). The set of all these vectors connected by arrows repre-
sent the transitions between network states. To know whether
the same vectors are active several times, similarity maps were
constructed and all possible vector pairs were compared along
time. The similarity index between any pair of vectors is defined
by their normalized scalar product (Sasaki et al., 2007; Carrillo-
Reid et al., 2008, 2009b): the cosine of the angle between the
compared vectors. High similarity between vectors means that
the activity of almost the same cells (same neuron pool) gener-
ated them at different times (Schreiber et al., 2003; Carrillo-Reid
et al., 2008, 2009a; Jáidar et al., 2010). Different vectors (dif-
ferent neuron pools) are denoted by different colors in raster
plots, activity histograms and locally linear embedding (LLE)
graphs.
The method used to detect the dynamics of network states
frommultidimensional vectors has been published (Carrillo-Reid
et al., 2008, 2009b; Jáidar et al., 2010). Briefly, dimensionality
of population vectors representing network states was reduced
by LLE, a dimensionality reduction technique that preserves the
structure of non-linear multidimensional data (Roweis and Saul,
2000; Brown and Williams, 2005; Carrillo-Reid et al., 2008).
Vectors are then projected into a two dimensional space. As a
result, it is possible to visualize clusters of data points represent-
ing the recurrence of similar vectors with similar pools of neurons
(network states) alternating their activity. Their sequences of acti-
vation may follow cycles or reverberation denoted by arrows
(Schreiber et al., 2003; Sasaki et al., 2007; Carrillo-Reid et al.,
2008, 2009b; Jáidar et al., 2010). To choose the optimal number of
network states we used hard and fuzzy clustering algorithms and
the Dunn’s index as a validity function (Bezdek and Pal, 1998;
Sasaki et al., 2007; Carrillo-Reid et al., 2008, 2009b).
Global neuronal activity over a given time was also rep-
resented by cumulative distributions of all cell activity in a
given epoch. The rates of accumulation were approximated with
ad hoc linear regressions. Their average slopes ± their esti-
mation errors were compared for significant differences with
non-paired Student’s t tests, experiment by experiment. Average
significance is reported. In addition, for sample comparisons
of these parameters we used Wilcoxon’s T statistic for paired
samples and Mann-Whitney U statistic for non-paired samples
(Plata et al., 2013).
THE 6-OHDA HEMI-PARKINSONIAN MODEL
Hemiparkinsonian animals, rats or BAC-mice, were obtained
as previously reported (Jáidar et al., 2010). Briefly, animals
were anesthetized with ketamine (85mg/kg, i.p.) plus xylazine
(15mg/kg, i.p.) while immobilized on a stereotactic frame.
Each animal received a unilateral injection of 6-OHDA (8μg
in 0.2μl with 0.2mg/ml of ascorbic acid) 0.1μl/1min in the
substantia nigra pars compacta (SNc coordinates: 3.8mm cau-
dal, 1.8mm lateral to bregma, and 7.1mm ventral to the skull
surface in rats and 2.6mm caudal, 0.7mm lateral to bregma
and 4.5mm ventral to the skull surface in post natal day
21 mice).
As described before (López-Huerta et al., 2012), the degree
of DA deprivation was tested provoking turning behavior 8 days
after the surgery using automated rotometers and amphetamine
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(4mg/kg, i.p.). Because these protocol has been extensively
reported in several occasions (6-OHDA model; e.g., López-
Huerta et al., 2012), here will not be reported in the Results,
but only as a method to obtain hemiparkinsonian animals.
Left and right full body turns were recorded for 90min by
a home-made computerized monitor. Animals showing >500
turns ipsilateral to the injected side were considered for further
experiments.
RESULTS
CELL ASSEMBLY DYNAMICS IN THE STRIATAL MICROCIRCUIT
Figure 1A illustrates a raster plot or matrix showing the activ-
ity of >100 neurons in a field of view within a striatal slice in
control conditions. Each row in the plot represents the electri-
cal activity of one neuron across a series of images (columns)
recorded bymeans of calcium-imaging using fluo-8 (seeMaterials
andMethods). Leftmost frame shows 3min of activity (an epoch)
in control striatal tissue without NMDA: note the scarcity of
spontaneous activity and the absence of significant peaks of syn-
chronization. In the next three frames (3 epochs 3min each) it
is shown an increase in activity involving dozens of striatal indi-
vidual neurons (single cell resolution) after adding 2μM NMDA
into the bath saline. All three epochs display the NMDA-induced
activity. Colored dots denote neurons firing together and belong-
ing to a pool of neurons. Different colors denote different neuron
pools. The activity of these neurons is vectorized (column vec-
tors). Note that neuronal vectors alternate their activity along
time, that is, the network transits from one set of neurons to the
other as indicated by different colors.
Activity histogram at bottom represents (Figure 1B) the
summed neuronal activity of the matrix above, column by col-
umn, over time. Therefore, it represents a multicellular or popu-
lation recording but with the possibility of locate and count each
of the cells composing the peaks of synchronization (Carrillo-
Reid et al., 2008, 2009a). The dashed horizontal line shows the
level of statistical significance for the peaks of synchronization
(obtained by Monte Carlo simulations, see above). Note that sev-
eral peaks of neuronal synchronization, denoted by colors, cross
this level, indicating that sets neurons synchronize their firing sig-
nificantly and spontaneously and then alternate their activity with
other synchronous neuron pools. Similarity index (Figure 1C)
compares each neural vector with all others over time: a patchy
appearance shows that similar and several vectors were in charge
of activity through the time. Dimensionality reduction of neu-
ronal vectors using LLE shows the same vectors projected into
a two dimensional space with no units (Figure 1D; Carrillo-
Reid et al., 2009a). Similar vectors group together (denoted by
different colors) indicating various (3) network states in the
circuit. Transitions between network states follow determined
sequences or trajectories (arrows). Percentages give the proba-
bility of leaving a given network state. In this way, we can say
that the group of neurons in the field of view shows cell assem-
bly dynamics (Carrillo-Reid et al., 2008, 2009a). Note that in the
control without NMDA (leftmost epoch in Figure 1A) there is
no assembly dynamics. In the next three Figures, control activ-
ity indicates activity in the presence of 2μM NMDA, that is,
cell assembly dynamics or circuit activity. It is in this activity
where we tested the global action of nicotine in the striatal
circuitry.
GLOBAL ACTION OF NICOTINE IN THE ACTIVITY OF THE STRIATAL
MICROCIRCUIT IS INHIBITORY
Raster plot in Figure 2A illustrates three epochs (3min each sep-
arated by dashed vertical lines): the left epoch shows an activity
similar to that described in Figure 1A in the continuous pres-
ence of 2μM NMDA (arrow; NMDA was present all the time
during this experiment): this activity reveals significant peaks
of synchronization in the activity histogram below, the mani-
festation of assembly dynamics (Figure 2B colored). In NMDA
presence, addition of 1μM nicotine to the bath saline (middle
epoch) drastically reduced the level of neuronal activity (hori-
zontal bar indicates time of nicotine exposure). Nicotine reduced
most circuit activity: less dots, absence of significant peaks syn-
chronization. Note that the actions of nicotine were reversible
upon washing (right epoch). Histogram of multicellular activity
(Figure 2B; note significance level indicated by a dashed horizon-
tal line) shows spontaneous and significant peaks of synchroniza-
tion only in the presence of NMDA alone. Addition of nicotine
abolished the peaks of synchronized activity even in the presence
of NMDA (Figure 2B). Nonetheless, after nicotine was washed
off, the peaks of synchronization begin to return (right epoch).
By summating all activity from histogram in Figure 2B over time
(all bars in the histogram for each epoch), we obtained a graph
of cumulative cell activity (Figure 2C). It shows that total circuit
activity in the presence of NMDA is much higher (ad hoc fitting of
straight lines where slopes become the rate of accumulation along
time ± estimation error). An average of a sample of experiments
yields 479 ± 2 (act/min), which decays to 190 ± 1.5 (act/min)
during nicotine (n = 6 slices; P < 0.005). Figure 2D shows the
similarity matrix when nicotine is not present reassuring that
assembly dynamics was present during NMDA. In addition, we
counted the number of significant peaks of synchronization per
epoch in the presence of NMDA and during nicotine in the con-
tinuous presence of NMDA (Figure 2E): an average of 3.3 ± 1.2
peaks/epoch in the control (NMDA) vs. 0.16 ± 0.4 peaks/epoch
in the presence of nicotine (n = 6 slices; n = 3 epochs per slice;
∗∗P < 0.025).
Figure 3 shows that actions of nicotine were blocked by 10μM
mecamylamine, a non-selective and non-competitive antago-
nist of nAChrs (n = 4). NMDA produced the usual increase
in circuit activity with spontaneous and statistically significant
peaks of synchronization (Figures 3A,B left epoch; NMDA was
present during the whole experiment). This activity was greatly
decreased when nicotine was added to the bath (middle epoch
in Figures 3A,B), when significant peaks of synchronization dis-
appeared, denoting that many individual neurons stopped firing
(dots in the matrix). However, they partially returned when
mecamylamine was added in the presence of both NMDA and
nicotine (Figures 3A,B right epoch), suggesting that the actions
of nicotine were receptor specific. A more complete character-
ization of the nicotinic receptors involved is out of the scope
of the present report. Cumulative plots (Figure 3C) show that
circuit activity is significantly lowered only when nicotine was
added: an average of the sample of experiments yields 163 ±
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FIGURE 1 | Assembly dynamics in the control striatal circuitry after
NMDA. (A) Raster plot showing the simultaneous activity of >100
neurons in a striatal slice using calcium-imaging. Each row in the matrix
represents the activity of a single neuron across the series of images
(columns). Left epoch shows 3min of activity in control striatal tissue
without NMDA. Note scarce activity and the absence of peaks of
synchronization. In the next three epochs, separated by dashed vertical
lines, 9min of activity are shown after adding 2μM NMDA into the
bath saline (denoted by horizontal black line on top). Note that many
more dots, some of them colored, populate the matrix. Colored dots
denote the synchronized activity of several neurons in a given column
or neighboring columns (a neuron pool is then represented as a
column vector). Note that different neuron pools produce the circuit
activity along time. (B) Activity histogram at bottom is the summed
neuronal activity (multicellular activity) from the raster plot above
column by column (frame by frame in a given movie). The dashed line
shows the level of significance for the spontaneous peaks of
synchronization denoted by colors (obtained by Monte Carlo simulations;
statistically significant neuronal vectors; n = 6 slices). (C) A similarity
index matrix compares each vector with all others along time: a patchy
appearance shows that similar vectors were in charge of activity. (D)
Dimensionality reduction using locally linear embedding (LLE) shows
neuronal vectors projected in a two dimensional space with no units.
Similar vectors grouped together (denoted by different colors) give raise
to network states. The transitions among network states are denoted
by arrows. Percentages give the probability to leave a given state.
Colored dots and arrows represent the sequential activity of the circuit,
that is, pools of neurons synchronized their firing and pass their activity
from one pool of neurons to the other: cell assembly dynamics
(Carrillo-Reid et al., 2008). Note reverberant trajectories in the sequence.
Here and in the next figures, epochs (times of continuous image
series) are separated by vertical dashed lines.
1.3 (act/min) in NMDA, which decays to 51 ± 0.7 (act/min)
during nicotine (n = 3; average significance of P < 0.01). Note
that subsequent addition of mecamylamine produced a return
in the tendency of cumulative activity (green trace), even in the
continuous presence of nicotine. The vectors similarity matrix
reassured that NMDA-induced activity had assembly dynamics
(Figure 3D). Histogram in Figure 3E shows average of synchro-
nization peaks taken from several control slices in the presence
of NMDA: 3.6 ± 0.34 peaks per epoch (n = 10 slices and n = 10
epochs). This average decreased significantly when nicotine was
added to the superfusion: 0.2 ± 0.13 peaks per epoch (∗∗∗P <
0.001; n = 10 slices and n = 10 epochs). Note that when the non-
selective nAChr antagonist, mecamylamine, was added to the bath
saline, the peaks of synchronization returned gradually and sig-
nificantly: 2.7 ± 0.33 peaks per epoch (∗∗P < 0.01; n = 4 slices;
n = 6 epochs).
In summary, nicotine was capable to reduce circuit activ-
ity in the striatal network and its actions were both reversible
(Figure 2) and blocked bymecamylamine (Figure 3). But nAChrs
are ionotropic channels that carry inward currents that should
excite, not inhibit circuit activity, just as NMDA-receptors. How
it is possible that two ionotropic cationic receptors have opposite
actions in the same circuit? According with some cell-focused
studies, we hypothesized that the actions of nicotine were indi-
rect via the activation of striatal GABAergic interneurons (e.g.,
English et al., 2011; Ibáñez-Sandoval et al., 2011; Luo et al., 2013).
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FIGURE 2 | Global actions of nicotine in the striatal circuit are inhibitory.
(A) Raster plot illustrating three brief epochs (3min each) taken from larger
movies (as in Figure 1A). Left epoch: the simultaneous activity of 80 neurons
in the continuous presence of NMDA (2μM; denoted by an arrow, cf.,
Figure 1). The arrow denotes that NMDA is maintained all the time during
this experiment. Colored dots show neuronal vectors indicating spontaneous
synchronous activity of neuron pools. Middle epoch: nicotine (1μM) is added
to the bath saline in the presence of NMDA. Note that activity is decreased
and the absence of colored dots indicates that spontaneous events of
synchronization are now absent. Right epoch: a partial nicotine washing off,
two significant peaks of synchronization appear indicating that nicotine
actions were reversible. (B) Activity histogram displaying multicellular activity.
Significant peaks of synchronization (colored) appear during NMDA but not
after addition of nicotine even if NMDA is present. (C) Cumulative activity
taken from histogram in (B) (addition of all bars in the histogram over time in
a given epoch) shows that rate of accumulated activity was significantly
higher in the absence of nicotine. Nicotine lowered the rate of cumulative
activity significantly in all slices tested (n = 6 slices; n = 3 epochs per slice
were taken). (D) Matrix of vectors similarity along time, without nicotine.
(E) Histogram compares the appearance of peaks of synchronization per
3min epoch in NMDA and in NMDA plus nicotine: it is clear that nicotine
significantly abolished NMDA-induced synchronous activity. ∗∗P < 0.025.
To see if this latter hypothesis was true we tried to block nicotine
effects on the circuit with GABAA-receptor antagonists.
INHIBITORY ACTION OF NICOTINE IN THE STRIATAL CIRCUIT IS
BLOCKED BY GABAA-RECEPTOR ANTAGONISTS
Figure 4A illustrates a raster plot with three epochs (separated by
dashed vertical lines). At left, the usual neuronal activity found in
striatal tissue after addition of 2μM NMDA in the bath is shown
(cf., Figure 1). Significant peaks of synchronization are present
(Figure 4B left epoch; blue and red). At the middle epoch, 1μM
nicotine plus 10μM bicuculline were added. In contrast with
the action of bicuculline alone, where the activity of the circuit
increases using the same pool of neurons over and over again (see
Figure 8 in Carrillo-Reid et al., 2008 and Figure 5 in Jáidar et al.,
2010), bicuculline together with nicotine, generated an activity
of the circuit that displayed an increase of synchronization peaks
(Figures 4A,B middle epoch). In these conditions, nicotine did
not restrain circuit activity anymore and the induced activity
consisted in a frenzy sequence of peaks coming from different
neuron pools that alternate their activity without pace. 10μM
gabazine had the same results when administered with nicotine
(n = 3; not shown but see: López-Huerta et al., 2012, 2013).
Alternations among neuronal pools became frequent and rarely
repeated.
In summary, bicuculline added alone increased activity based
in a single or dominant peak of synchronization (see Carrillo-
Reid et al., 2008; Jáidar et al., 2010), nicotine added alone,
decreased the activity and peaks of synchronization disappeared
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FIGURE 3 | Global actions of nicotine in the striatal circuit are blocked
by mecamylamine. (A) Raster plot showing circuit activity in the presence
of NMDA. Similarly to Figure 2A, left epoch shows activity with
spontaneous synchronization of different neuron pools (colored dots).
Middle epoch: nicotine (1μM) added to the bath saline in the presence of
NMDA induced a decrease in activity and the absence of color indicates
that significant events of spontaneous synchronization are now absent.
Right epoch: addition of 10μM mecamylamine allowed the return of some
peaks of synchronization showing that the activity of nicotine was receptor
dependent (n = 3 slices; 6 epochs). (B) Activity histogram displaying
multicellular activity from the raster plot above. Significant peaks of
synchronization (colored) appear during NMDA. They disappeared when
nicotine was added and reappeared after addition of mecamylamine to the
bath saline. (C) Cumulative activity taken from histogram in (B) shows that
rate of accumulated activity was significantly lower in the presence of
nicotine plus NMDA than with NMDA alone. It is also shown that
mecamylamine virtually restored the level of accumulated activity over
time in the continuous presence of both NMDA and nicotine. (D) Matrix of
vectors similarity along time reassured that activity in NMDA is due to
network activity. (E) Histogram showing that the number of peaks of
synchronization per epoch decreased significantly when nicotine was
added in the presence of NMDA-induced activity (∗∗∗P < 0.001) and then
increased again, significantly (∗∗P < 0.01), when mecamylamine was added
in the presence of nicotine.
(Figure 2), but nicotine added with bicuculline increased activity
based on an increase in the peaks of synchronization (Figure 4;
cf., middle epoch with left and right epochs). The wash off
of both drugs returned the circuit to usual levels in terms of
activity during NMDA (Figures 4A,B right epoch). Similarity
matrix includes vectors activity with bicuculline and nicotine
(Figure 4C). Dimensionality reduction LLE compares circuit
dynamics before (Figure 4D left; only two states red and blue) and
after nicotine plus bicuculline (Figure 4D right; four states). Note
that transitions between network states drastically augmented.
This action was surprising in the sense that it suggests that sev-
eral different sets of neurons are being activated by nicotine in
spite of blocking GABAA-receptor transmission, as in the case of
DA D2-receptor agonist action in the striatal circuit (cf., Figure
5B in Carrillo-Reid et al., 2011).
PARKINSONIAN ACTIVITY IN DOPAMINE DEPLETED STRIATUM IS
REDUCED BY NICOTINE
A mice sample was lesioned unilaterally with 6-OHDA. The
degree of DA deprivation in the striatal tissue was tested
provoking turning behavior 8 days after the surgery using
automated rotometers and amphetamine (4mg/kg, i.p.). Animals
showing >500 turns ipsilateral to the injected side were consid-
ered for further experiments (López-Huerta et al., 2012).
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FIGURE 4 | Global actions of nicotine in the striatal circuit are blocked
by bicuculline. (A) Raster plot showing again three different epochs of
activity. At the left epoch, the typical activity of the striatal circuit with
2μM NMDA is seen displaying two neuron pools with synchronized
activity (red and blue). Middle epoch: neuronal activity is dramatically
increased due to the addition of 1μM nicotine plus 10μM bicuculline into
the bath saline. In contrast with what happens when bicuculline is
administered alone (Carrillo-Reid et al., 2008), nicotine plus bicuculline
showed a quite diverse set of synchronization peaks. Right epoch: nicotine
plus bicuculline actions were reversible. (B) Activity histogram of summed
multicellular activity showing that in control (left) there are five peaks of
spontaneous synchronization belonging to two different neuron pools (blue
and red). Peaks of synchronization increase in number and classes when
both nicotine and bicuculline are added to the bath (middle epoch). When
bicuculline is given alone, circuit activity is manifested by a highly recurrent
peak of synchronization (Carrillo-Reid et al., 2008). Right epoch: activity
begins to return to normal after the drugs were washed off. (C) Similarity
matrix in the presence of both drugs. (D) LLE before (NMDA left) and after
addition of nicotine plus bicuculline (right): note more network states and
more transitions in circuit activity when both drugs are present.
As already reported (Jáidar et al., 2010), the DA depleted
striatum exhibited spontaneous activity and peaks of statisti-
cally significant synchronization that appear spontaneously in the
absence of NMDA or any other excitatory drive (Figures 5A,B;
first three epochs). This pathological activity is different to the
one recorded in the control striatum without NMDA (leftmost
epoch in Figure 1A). It is also different than NMDA-induced
activity in control tissue (Carrillo-Reid et al., 2008; Jáidar et al.,
2010). First three epochs in the raster plot of Figure 5A show
Parkinsonian activity followed by addition of nicotine in the last
two epochs. In fact, nicotine was added after the beginning of the
fourth epoch to appreciate the quick action of nicotine. Activity
histogram (Figure 5B) shows that the DA-depleted microcircuit
presents significant peaks of synchronization. Note however, that
in this case the peaks are composed by the same pool of neu-
rons (same color red), having recurrent activity once and again
(Jáidar et al., 2010) as it is the case with bicuculline actions
when it is given alone (Carrillo-Reid et al., 2008). In other words,
DA-depletion produces an increased activity with no alternation.
Interestingly, addition of 1μM nicotine to the bath saline (last
two frames) abolished Parkinsonian activity and the peaks of
synchronization (last two epochs in Figures 5A,B). Cumulative
activity clearly showsmore activity over time for the Parkinsonian
microcircuit (Figure 5C): average rate of activity over time in
the DA deprived circuit was: 170 ± 1 (act/min) while it was
54 ± 0.4 (act/min) after nicotine (n = 6; P < 0.006), showing
that nicotine significantly reduced pathological activity.
As previously reported (Jáidar et al., 2010), peaks of synchro-
nization were made by similar neuronal vectors or the same
network state having recurrent activity, according to similarity
index and LLE analysis (Figures 5D,E; Jáidar et al., 2010). Note
LLE (Figure 5E) showing the same network state recurring on
itself absorbing all synchronized neurons, suggesting that this is
the microcircuit correlate of Parkinsonian slow oscillations. It
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FIGURE 5 | Nicotine inhibits Parkinsonian activity in the dopamine
depleted striatal microcircuit. (A) Raster plots showing five epochs of
activity in a DA-depleted striatal circuit. There is spontaneous neuronal
activity in the absence of NMDA (first three epochs shows activity in a
6-OHDA rodent model of hemi-Parkinsonism, see Materials and Methods).
However, significant synchronization is composed of the same neuron pool.
Last two epochs show that nicotine reduces this activity. (B) Note that
activity during DA deprivation exhibits significant peaks of synchronization.
However, all are depicted with the same color since similarity indexes
indicate that these vectors are built with a similar set of neurons presenting
correlated activity in a recurrent mode. Note that these peaks disappear
during nicotine. (C) Cumulative activity is significantly higher during
DA-depletion than during DA-depletion with nicotine. (D) Similarity matrix
shows similar neuronal vectors dominating the activity through the time in
the DA depleted microcircuit. (E) LLE shows that the same network state
keeps repeating its firing over time in the DA depleted tissue (all dots are of
the same group-color), as though the circuit could not leave this dominant
network state (Jáidar et al., 2010). Nicotine was capable to suppress this
recurrent network state significantly. (F) The histogram shows that peaks of
spontaneous synchronization are virtually abolished by nicotine. ∗∗∗P < 0.005.
was surprising that nicotine was capable to suppress the excess
in activity and the dominant network state. Finally, we also quan-
tified the number of synchronization peaks per epoch: it was an
average of 4.2 ± 1.7 peaks/epoch (n = 6 slices; n = 18 epochs) in
a sample of DA deprived slices and 0.3 ± 0.7 (peaks/epoch) in DA
deprived slices during nicotine treatment (Figure 5F; n = 6 slices;
n = 12 epochs; ∗∗∗P < 0.005). In fact, the action of nicotine in
this early Parkinsonian tissue is as potent as that of L-DOPA (cf.,
Plata et al., 2013).
DISCUSSION
Global action of nicotine in the striatal microcircuit reduced both
the NMDA-induced neuronal activity in control tissue and the
Parkinsonian pathological activity in the rodent 6-OHDA model
of PD. However, nicotine, as NMDA, is an agonist of ligand-gated
ionotropic channels whose role is to generate inward currents
and depolarize target neurons. Nevertheless, each one of these
agonists, NMDA and nicotine, has a completely different and even
opposed action in the striatal circuit.
Cell-focused studies have disentangled an array of different
actions of nicotine at the cellular and synaptic levels. First, nico-
tine activates nAChrs in incoming glutamate terminals inducing
glutamate release (e.g., Marchi et al., 2002; Zhang and Warren,
2002; Campos et al., 2010). If this action were the predominant
action at the microcircuit level, then it would be facilitatory of
circuit activity and add to the activation produced by NMDA in
the control circuit or to the pathological activity found in the
DA-depleted circuit. This was not the case.
Second, nicotine also activates dopaminergic synapses induc-
ing DA release (e.g., Wonnacott et al., 2000; Grady et al., 2007;
Keath et al., 2007; Livingstone and Wonnacott, 2009; Xiao et al.,
2009; Cachope et al., 2012; Threlfell et al., 2012). This action
taken alone would lead to the induction of some kind of activity
in the network (Carrillo-Reid et al., 2011) although this activity
would be unpredictable solely based in cell-focused studies. On
the one hand, DA induces firing in striatal interneurons. This
action would favor inhibition of the circuit (Bracci et al., 2002).
Nevertheless, besides postsynaptic activation of interneurons, DA
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also inhibits the release of GABA from the terminals of the same
or different interneurons (Centonze et al., 2003). This, apparently,
is a contradictory result. The end result of both actions taken
together is hard to infer with cell-focused studies alone. This fact
supports the need to observe actions of transmitters at the net-
work level, and not only at the cellular level. Also, when seen at
the circuit level, both classes of DA receptors, D1 and D2, induce
an increase in spontaneous synchronized activity (Carrillo-Reid
et al., 2011). Besides, individual SPNs may be inhibited or excited
by DA (e.g., Kiyatkin and Rebec, 1996; Carrillo-Reid et al., 2011)
depending on context. Taken one by one, it is difficult to make
sense of all these actions and any inference about the end results is
precluded. This fact supports the direct study of the global action
in the microcircuit as a whole.
Furthermore, in case the activity of the circuit is increased due
to DA-depletion (Jáidar et al., 2010), collateral inhibition among
SPNs is decreased, and most actions of nicotine would be on
GABAergic synapses made by interneurons. In such a case, DA
analogs, such as L-DOPA, completely restore the control activ-
ity of the circuit, dramatically and reversible, being this action a
neuronal correlate of behavioral and clinical trials (Plata et al.,
2013). Accordingly, one question of the present work is howmuch
nicotinic actions approximate that of L-DOPA.
Third, nAChrs actions have also been recorded in striatal
GABAergic interneurons during cell-focused studies: nicotinic
activation of several interneuron types such as fast-spiking (FS),
low-threshold spiking (LTS), tonically firing neurogliaform cells,
and others, release GABA upon nicotinic activation and inhibit
projection neurons (Koós and Tepper, 2002; Wilson, 2004;
Kreitzer and Malenka, 2008; Livingstone and Wonnacott, 2009;
Xiao et al., 2009; English et al., 2011; Ibáñez-Sandoval et al., 2011;
Luo et al., 2013). As the cell-focused studies described above,
this appears to be another important action of nicotine when
observed in isolation, cell by cell.
To conclude, cell-focused studies have revealed a host of mixed
and parallel actions, some pointing to inhibitory and others
to excitatory types of activity. Taken together, all these actions
make hard to foretell what would be the global action of nico-
tinic receptors activation on the striatal microcircuit as a whole.
The importance of answering this question is that clinical stud-
ies claim improvements of motor and cognitive symptoms in
PD patients subjected to nicotine analogs (Fagerström et al.,
1994; Villafane et al., 2007), that is, after systemic administration.
Moreover, some epidemiological studies claim less incidence of
PD in smokers (Gorell et al., 1999; Herman et al., 2001; Driver
et al., 2009). Therefore, it is logical to question about what is the
predominant action of nicotine in the striatal circuit when tonic
concentrations are raised. To observe the answer to this matter
directly at the microcircuit level, some type of multicell record-
ing and therefore, a more sophisticated analysis, are required.
However, the results surpassed any expectation about which of
the mixed and parallel actions described in cell-focused studies
predominates: nicotine readily and reversibly decreased control
(with NMDA) and Parkinsonian activity. This observation gives
raise to perhaps more important questions: what is the rela-
tion between nicotine actions and its supposed anti-Parkinsonian
activity? Could it be used as an adjunct therapy in PD?
In summary, we demonstrate that the predominant action of
a tonic elevation in nicotine concentration in the striatal micro-
circuit is the inhibition of network activity through the activation
of GABAergic transmission, since inhibitory nicotinic action was
blocked by GABAA-receptor antagonists. Secondly, the inhibitory
activity could be either on the assembly dynamics induced by
an uncorrelated excitatory drive such as NMDA (Carrillo-Reid
et al., 2008), or else, on the pathological activity derived from
DA depletion (Jáidar et al., 2010) in early Parkinsonian animals
models.
In the second case, nicotinic action is a microcircuit corre-
late of the already described anti-Parkinsonian actions of nicotine
(Fagerström et al., 1994; Gorell et al., 1999; Costa et al., 2001;
Herman et al., 2001; Villafane et al., 2007; Driver et al., 2009;
Quik et al., 2007; García-Montes et al., 2012; Kawamata et al.,
2012). Indeed, in comparison to our early Parkinsonian animal
models (Jáidar et al., 2010), we show that the action of nicotine
is almost as strong as that of L-DOPA (Plata et al., 2013). Such a
strong anti-Parkinsonian action at the circuit level was certainly
unexpected.
Many classes of striatal interneurons are known to express
nAChrs and are capable to be activated by nicotinic analogs
(Koós and Tepper, 2002; Wilson, 2004; Quik et al., 2007; Kreitzer
and Malenka, 2008; Livingstone and Wonnacott, 2009; Xiao
et al., 2009; English et al., 2011; Ibáñez-Sandoval et al., 2011;
Luo et al., 2013). As a result, they release GABA and inhibit
SPNs. This inhibition is blocked by GABAA-receptor antagonists
such as bicuculline (e.g., English et al., 2011; Ibáñez-Sandoval
et al., 2011; Luo et al., 2013). Accordingly, here it is shown
that global inhibitory nicotinic actions could be blocked with
GABAA-receptor antagonists such as bicuculline suggesting that
the strong decrease in circuit activity, normal or pathological,
is due to massive interneurons activation. In fact, the action of
bicuculline alone in the circuit has been reported both in con-
trol activity (with NMDA; Carrillo-Reid et al., 2008) and in
Parkinsonian activity (with DA-depletion; Jáidar et al., 2010).
When administered alone, bicuculline produces an increase in
activity, but similarly to Parkinsonian activity it is character-
ized by a dominant pool of neurons having spontaneous syn-
chronization in a recurrent way (Carrillo-Reid et al., 2008). In
the DA-depleted tissue, activity entrenches the dominant state
produced by DA absence destroying the alternating dynamics
that may remain (Jáidar et al., 2010). In contrast, when bicu-
culline was given in the presence of nicotine, a plural set of
peaks of synchronization appeared, manifesting a strong assem-
bly dynamics with abundant trajectories in the LLE plot. This
behavior suggests that several classes of interneurons are being
activated.
Further research is needed to find out which of the interneuron
classes predominate over the others, since each element of the cir-
cuit may express a different nAChr. The importance of this future
dissection about the mechanism of how these powerful nicotinic
action may happen is that it is known that PD course with hyper-
cholinergia (rev in: Pisani et al., 2005; Goldberg and Reynolds,
2011) and that some types of interneurons become hyperexcitable
during DA depletion (Dehorter et al., 2009), a result that appear
as counter-intuitive given the present data. Therefore, this action
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may involve the activation of a specific interneuron network (with
a specific nAChr-class). A strong candidate is the neurogliaform
interneuron which releases abundant GABA setting the stage for
volume transmission (Ibáñez-Sandoval et al., 2011). Alternatively,
nicotine may favor the synchronized network activity of an
interneuron network united by gap junctions (Tepper et al.,
2010). In both cases, activation of these neurons may be capa-
ble to inhibit the interneurons that are overactive during PD
(Dehorter et al., 2009), including perhaps, the cholinergic ones.
This future research may find that a specific receptor is involved,
a necessary step to find selective ligands with potential therapeu-
tic use. Finally, in vivo experiments are needed to answer another
question: how such a potent inhibition would allow common
motor tasks.
In any case, the present results highlight the possibility of using
nicotine analogs as an adjunct to L-DOPA in PD therapy.
The increase in DA release induced by nicotine may have its
own beneficial actions as long as some DA-terminals still remain
(Wonnacott et al., 2000; Grady et al., 2007; Keath et al., 2007;
Livingstone and Wonnacott, 2009; Xiao et al., 2009; Cachope
et al., 2012; Threlfell et al., 2012). A possible difficulty is that
DA and glutamate release are tied together, and have a recipro-
cal interaction and regulation. In any case, here, we present a
bio-assay that allows the evaluation of control and pathological
activity of the striatal microcircuit in which the actions of drugs
with suspected therapeutic actions may be tested and compared
with usual behavioral assays.
CONCLUSION
Calcium imaging techniques may serve to design bio-assays to
test potential anti-Parkinsonian drugs in in vitro brain slices.
Here, we tested nicotine, which has been suspected to pos-
sess anti-Parkinsonian activity for a long time. Indeed, it had
an action similar to L-DOPA assayed in the same preparation
(cf., Plata et al., 2013). However, both drugs were assayed in
early Parkinsonian animals tested with turning behavior as a
correlate of DA-deprivation. Further research is needed to test
nicotine analogs in later stages of the disease, as for example, in
dyskinesias.
In addition, we searched the mechanism of nicotinic actions
which turned out to be indirect: the global effect of elevating the
tonic concentration of nicotine in the striatal microcircuit was
that of inhibiting the circuit in a way that was blocked by GABAA-
receptor antagonists, that is, most probably by activating a set of
inhibitory interneurons. Further research is needed to find out
which neurons and nAChRs are involved in these actions. But of
the many parallel and sometimes contradictory actions that have
been described separately in cell-focused studies, the activation of
interneurons appeared to be the predominant one.
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